TOP STORIES

• REGULATORY BeiGene’s Brukinsa, J&J’s Balversa and More Now in Line for Japan Approval
  October 31, 2024

• BUSINESS 604 Employees Raise Hands for Sumitomo’s Buyout Program
  October 31, 2024

• ACADEMIA 50% of Quit-Smoking Clinics Closed or Suspended, Will Champix Re-Supply Bring Them Back Online?
  October 30, 2024

• REGULATORY Ruling Bloc’s Loss of Lower House Majority Might Sway Off-Year Revision Debates
  October 29, 2024

• REGULATORY LDP Loses Big in Snap Election, Many Health-Savvy Members Ousted
  October 28, 2024

• BUSINESS AbbVie Taps Tiago Campos Rodrigues as Japan President
  October 28, 2024

• BUSINESS Recordati to Enter Japan’s Hematology/Oncology Market with Enjaymo Acquisition
  October 25, 2024

• BUSINESS NHI-Market Price Gap Expected to Contract in 2024, Will It Enter Lower 5% Territory?
  October 24, 2024

• BUSINESS CEA Is “Wrong Tool” That Doesn’t Fit into Japanese System: J&J Exec
  October 23, 2024

• REGULATORY LDP’s Hashimoto Makes Rare Speech on Drug Prices amid Close Race in Okayama
  October 22, 2024

• BUSINESS Pfizer Veteran Pullicino to Lead Novartis Japan
  October 22, 2024

• BUSINESS Ferring Japan Set for 15% Annual Growth as It Gazes at Gene Therapy Debut
  October 21, 2024

• BUSINESS Moderna CEO Maintains Future Vision for Product Mix despite R&D Cutback, Eyes Leap with Flu-COVID Shot
  October 18, 2024

• BUSINESS Ultragenyx Looks to Launch 6 New Products in Japan by 2028-End: CCO
  October 17, 2024

• REGULATORY Multiple Candidates Tout Drug Policies as Snap Poll Campaigning Starts
  October 16, 2024

• BUSINESS Shonan iPark Set for Expansion as It Looks to Establish Profile as Regenerative Medicine Hub
  October 16, 2024

• REGULATORY Japan Political Parties Push Varied Pharma Policies as Election Campaign Kicks Off
  October 15, 2024

• ORGANIZATION EFPIA Chief Sees Positive Signal from Japan Policymakers, Calls for Consistency
  October 11, 2024

• REGULATORY Kisunla to Follow Same Rules as Leqembi in Pricing and Post-Launch Review
  October 10, 2024

• BUSINESS Pfizer Curbs Supply of Avastin Biosimilar, 2 Others Hit by Knock-On Effect
  October 9, 2024

ページ

• « 先頭
• ‹ Prev
• …
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• …
• Next ›
• 最終 »